Sputum Streptococcus pneumoniae is reduced in COPD following treatment with benralizumab by George L, Wright A, Mistry V, Sutcliffe A, Chachi L, Haldar K, Ramsheh MY, Richardson M, van der Merwe R, Martin U, Newbold P, Brightling CE

Get full text

DP2 antagonism reduces airway smooth muscle mass in asthma by decreasing eosinophilia and myofibroblast recruitment by Saunders, R, Kaul, H, Berair, R, Gonem, S, Singapuri, A, Sutcliffe, AJ, Chachi, L, Biddle, MS, Kaur, D, Bourne, M, Pavord, ID, Wardlaw, AJ, Siddiqui, SH, Kay, RA, Brook, BS, Smallwood, RH, Brightling, CE

Fevipiprant reduces airway smooth muscle mass in asthmatics via PGD2 receptor antagonism by Saunders, R, Kaul, H, Berair, R, Singapuri, A, Chernyavsky, I, Chachi, L, Biddle, M, Utcliffe, A, Laurencin, M, Bacher, G, Bourne, M, Pavord, I, Wardlaw, A, Siddiqui, S, Kay, R, Brook, B, Smallwood, R, Brightling, C

Fevipiprant reduced airway smooth muscle massin asthmatics via PGD2Receptor antagonism by Saunders, R, Sandrini, A, Kaul, H, Berair, R, Singapuri, A, Chernyavsky, I, Chachi, L, Biddle, M, Sutcliffe, A, Laurencin, M, Bacher, G, Bourne, M, Pavord, I, Wardlaw, A, Siddiqui, S, Kay, R, Brook, B, Smallwood, R, Brightling, C